Pulmonx Corporation LUNG Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 75.5%+1.3pp | 74.2%+0.9pp | 73.3%+0.2pp | 73.1%-0.4pp | 73.5%-0.5pp | |
| Operating margin | -58.8%+0.5pp | -59.3%+3.1pp | -62.4%+0.5pp | -62.9%+3.1pp | -66%+2.9pp | |
| Net margin | -60.1%-0.4pp | -59.7%+2.2pp | -61.9%+1.0pp | -62.9%+2.4pp | -65.3%+2.0pp | |
| Returns | ||||||
| Return on equity | -86.2%-9.0pp | -77.2%-3.5pp | -73.7%-6.8pp | -66.9%-6.2pp | -60.7%-5.4pp | |
| Return on invested capital | -92.1%-2.4pp | -89.6%-7.4pp | -82.2%-8.1pp | -74.1%-4.2pp | -69.9%-5.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×+0.1× | |
| Liquidity | ||||||
| Current ratio | 4.9×-0.2× | 5.1×+0.2× | 4.9×-0.5× | 5.3×+0.4× | 5×-0.6× | |
| Leverage | ||||||
| Debt-to-equity | 1.2×+0.2× | 1×+0.1× | 0.9×+0.1× | 0.8×+0.1× | 0.7×+0.1× | |
| Per Share | ||||||
| Book value per share | $1.09-17.9% | $1.33-9.3% | $1.47-14.2% | $1.71-12.1% | $1.94-11.4% | |
| Valuation | ||||||
| Market capitalization | $54.91M-43.7% | $91.16M+38.1% | $66.01M-39.2% | $108.49M-59.5% | $267.83M-0.1% | |
| Price / sales | 0.6×-0.5× | 1×+0.3× | 0.7×-0.5× | 1.2×-1.9× | 3.1×-0.1× | |
| Price / book | 1.3×-0.2× | 1.7×+0.6× | 1.1×-0.5× | 1.6×-1.9× | 3.4×+0.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulmonx Corporation's profit margins?
- Pulmonx Corporation (LUNG) runs a 75.5% gross margin and a -58.8% operating margin, with a -60.1% net margin.
- Where do Pulmonx Corporation's ratios come from?
- Every ratio is computed from Pulmonx Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
